血栓性微血管病变与乙型肝炎的干扰素治疗的关联:一个病例报告
Shan Wei1,2, Wenjuan Mei1, Ying Wang3
1Nephrology Department, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
Journal of medical case reports
|July 4, 2024
概括
干扰素治疗可能会导致血栓性微血管病变,这是一个罕见但严重的副作用,导致急性损伤. 及时停止干扰素治疗可以帮助改善功能.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血栓性微血管病 (TMA) 涉及微血管病的血液溶解性贫血,血栓细胞衰减和器官损伤,其特点是血管血栓症和内皮异常.
- 血栓细胞减小是干扰素治疗的一个已知的不良影响,而血栓性微血管病变是一种更罕见,更严重的并发症.
研究的目的:
- 报告一种干扰素诱导的血栓性微血管病变与急性损伤的病例.
- 以突出诊断挑战和治疗结果在这种情况下.
主要方法:
- 一个36岁的男性患有高血压,视力丧失,急性功能衰竭和TMA的病例报告.
- 脏活检显示了间歇性胀,动脉变化和 podocyte 融合.
- 免疫光检测显示C3和IgA沉积,与TMA和IgA脏病相一致.
主要成果:
- 这位患有乙型肝炎病史的患者在接受干扰素和tenofovir alafenamide fumarate治疗时发生了TMA.
- 诊断证实为干扰素诱导的TMA脏损伤.
- 在停止干扰素和接受治疗性血交换后,功能部分恢复.
结论:
- 干扰素可以诱导具有急性损伤的血栓性微血管病变.
- 这种情况可能会导致慢性功能衰竭,如果不及时管理.
相关概念视频
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...


